Wall Street analysts expect Tilray Inc (NASDAQ:TLRY) to post ($0.29) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Six analysts have provided estimates for Tilray’s earnings, with the highest EPS estimate coming in at ($0.22) and the lowest estimate coming in at ($0.39). Tilray reported earnings of ($0.08) per share during the same quarter last year, which would suggest a negative year over year growth rate of 262.5%. The business is scheduled to issue its next earnings results after the market closes on Tuesday, November 12th.
On average, analysts expect that Tilray will report full year earnings of ($1.09) per share for the current financial year. For the next financial year, analysts forecast that the firm will report earnings of ($0.81) per share, with EPS estimates ranging from ($1.34) to ($0.44). Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts that follow Tilray.
Tilray (NASDAQ:TLRY) last posted its quarterly earnings data on Tuesday, August 13th. The company reported ($0.32) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.09). The firm had revenue of $45.90 million during the quarter, compared to analysts’ expectations of $40.25 million. Tilray had a negative net margin of 121.73% and a negative return on equity of 37.64%. The business’s quarterly revenue was up 373.2% on a year-over-year basis. During the same quarter last year, the business earned ($0.17) earnings per share.
Hedge funds and other institutional investors have recently bought and sold shares of the company. Point72 Asset Management L.P. acquired a new position in shares of Tilray during the 2nd quarter valued at about $46,000. Wealthcare Advisory Partners LLC increased its stake in shares of Tilray by 100.8% during the 3rd quarter. Wealthcare Advisory Partners LLC now owns 996 shares of the company’s stock valued at $25,000 after acquiring an additional 500 shares during the last quarter. Certified Advisory Corp increased its stake in shares of Tilray by 152.1% during the 2nd quarter. Certified Advisory Corp now owns 1,041 shares of the company’s stock valued at $48,000 after acquiring an additional 628 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in shares of Tilray during the 2nd quarter valued at about $70,000. Finally, Advisory Services Network LLC increased its stake in shares of Tilray by 4,164.9% during the 2nd quarter. Advisory Services Network LLC now owns 1,578 shares of the company’s stock valued at $73,000 after acquiring an additional 1,541 shares during the last quarter. 7.66% of the stock is owned by institutional investors.
Shares of NASDAQ TLRY traded up $1.18 during trading on Tuesday, hitting $23.42. 2,221,600 shares of the company were exchanged, compared to its average volume of 1,915,118. The firm’s fifty day moving average price is $23.71 and its 200 day moving average price is $36.87. Tilray has a 1 year low of $20.20 and a 1 year high of $120.40. The company has a market cap of $2.19 billion, a price-to-earnings ratio of -28.56 and a beta of 4.32. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.04 and a quick ratio of 1.61.
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Featured Article: What does a neutral rating on stocks mean?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.